BridgeBio Pharma, Inc. (BBIO)

76.90 +0.50 (+0.65%) USD  |  NASDAQ  |  Dec 24, 10:51
More

BridgeBio Pharma SG&A Expense (TTM): 467.92M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Alnylam Pharmaceuticals, Inc. 1.181B
Supernus Pharmaceuticals, Inc. 442.58M
Ionis Pharmaceuticals, Inc. 351.68M
Regeneron Pharmaceuticals, Inc. 2.717B